Form D · Biotechnology
Renata Medical, Inc.
Santa Ana, CA · CIK 0001826012
Offering snapshot reported Sep 21, 2022 · SEC filing
- Reported sold
- $11.6M Offering amount: $12M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2022 | Initial | $11,557,978 | No comparison | 20 | SEC filing |
| Oct 7, 2020 | Initial | $4,356,608 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-459492
Source: Form D, filed Sep 21, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eason Abbott | Director, Executive |
| Dustin Armer | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
201 E. Sandpointe Ave., Ste. 370
Santa Ana, CA, 92707
Phone: (949) 610-5206
Santa Ana, CA, 92707
Phone: (949) 610-5206